1-4 of 4
Robin E Buckingham
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ, Inhibits the Jun NH2-Terminal Kinase/Activating Protein 1 Pathway and Protects the Heart From Ischemia/Reperfusion Injury

Nassirah Khandoudi, Philippe Delerive, Isabelle Berrebi-Bertrand, Robin E. Buckingham, Bart Staels, Antoine Bril
Journal: Diabetes
Diabetes 2002;51(5):1507–1514
https://doi.org/10.2337/diabetes.51.5.1507
Published: 01 May 2002
View article titled, Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ, Inhibits the Jun NH<sub>2</sub>-Terminal Kinase/Activating Protein 1 Pathway and Protects the Heart From Ischemia/Reperfusion Injury
Open the PDF for Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ, Inhibits the Jun NH<sub>2</sub>-Terminal Kinase/Activating Protein 1 Pathway and Protects the Heart From Ischemia/Reperfusion Injury in another window
Journal Articles

Thiazolidinedione Treatment Normalizes Insulin Resistance and Ischemic Injury in the Zucker Fatty Rat Heart

Robert J. Sidell, Mark A. Cole, Nicholas J. Draper, Martine Desrois, Robin E. Buckingham, Kieran Clarke
Journal: Diabetes
Diabetes 2002;51(4):1110–1117
https://doi.org/10.2337/diabetes.51.4.1110
Published: 01 April 2002
View article titled, Thiazolidinedione Treatment Normalizes Insulin Resistance and Ischemic Injury in the Zucker Fatty Rat Heart
Open the PDF for Thiazolidinedione Treatment Normalizes Insulin Resistance and Ischemic Injury in the Zucker Fatty Rat Heart in another window
Journal Articles

β-Cell Mass Dynamics in Zucker Diabetic Fatty Rats: Rosiglitazone Prevents the Rise in Net Cell Death

Diane T. Finegood, M. Dawn McArthur, David Kojwang, Marion J. Thomas, Brian G. Topp, Thomas Leonard, Robin E. Buckingham
Journal: Diabetes
Diabetes 2001;50(5):1021–1029
https://doi.org/10.2337/diabetes.50.5.1021
Published: 01 May 2001
View article titled, β-Cell Mass Dynamics in Zucker Diabetic Fatty Rats: <subtitle>Rosiglitazone Prevents the Rise in Net Cell Death</subtitle>
Open the PDF for β-Cell Mass Dynamics in Zucker Diabetic Fatty Rats: <subtitle>Rosiglitazone Prevents the Rise in Net Cell Death</subtitle> in another window
Journal Articles

Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Protects Against Nephropathy and Pancreatic Islet Abnormalities in Zucker Fatty Rats

Robin E Buckingham, Kamal A Al-Barazanji, C D Nigel Toseland, Mark Slaughter, Susan C Connor, Andrew West, Brian Bond, Nicholas C Turner, John C Clapham
Journal: Diabetes
Diabetes 1998;47(8):1326–1334
https://doi.org/10.2337/diab.47.8.1326
Published: 01 August 1998
View article titled, Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Protects Against Nephropathy and Pancreatic Islet Abnormalities in Zucker Fatty Rats
Open the PDF for Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Protects Against Nephropathy and Pancreatic Islet Abnormalities in Zucker Fatty Rats in another window